GMO U.S. Value ETF (NYSEARCA:GMOV – Get Free Report) was the target of a large growth in short interest in July. As of July 31st, there was short interest totaling 5,166 shares, a growth of 47.9% from the July 15th total of 3,493 shares. Approximately 0.2% of the company’s shares are short sold. Based on an average trading volume of 11,239 shares, the short-interest ratio is presently 0.5 days.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of the company. Fifth Third Bancorp purchased a new stake in shares of GMO U.S. Value ETF in the 1st quarter worth $84,000. Pathway Financial Advisors LLC purchased a new position in shares of GMO U.S. Value ETF during the second quarter valued at $246,000. Kestra Private Wealth Services LLC bought a new stake in shares of GMO U.S. Value ETF in the first quarter valued at about $333,000. Aspen Investment Management Inc bought a new stake in shares of GMO U.S. Value ETF in the fourth quarter valued at about $333,000. Finally, RPS Advisory Solutions LLC purchased a new stake in GMO U.S. Value ETF in the fourth quarter worth about $484,000.
GMO U.S. Value ETF Price Performance
Shares of NYSEARCA:GMOV traded up $0.10 during trading on Wednesday, reaching $32.38. 400 shares of the company were exchanged, compared to its average volume of 16,233. The business’s fifty day simple moving average is $30.94 and its 200-day simple moving average is $29.75. GMO U.S. Value ETF has a 12-month low of $25.66 and a 12-month high of $32.70. The firm has a market capitalization of $103.62 million, a PE ratio of 12.08 and a beta of 0.62.
About GMO U.S. Value ETF
The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.
See Also
- Five stocks we like better than GMO U.S. Value ETF
- Why Lowe’s Could Be a Bargain Before Housing Recovers
- Okta’s AI Tailwind Could Put This Forgotten Software Stock Back in Play
- Datavault AI Locks Down CyberCatch in $94M Security Rollup
- Quantum Stocks Are Starting to Choose Sides: Should Investors Do the Same?
Receive News & Ratings for GMO U.S. Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
